Burkett Financial Services’s Revolution Medicines RVMD Stock Holding History

Burkett Financial Services’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.3K	Buy	+133	New	+$26.4K	0.01%	215

Other funds holding RVMD

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Colton Groome Financial Advisors Asheville, North Carolina $427M AUM 13.21% 1-Year Est. Return

Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Burkett Financial Services's RVMD Position: Q3 2026 in Review

Burkett Financial Services opened a new position in Revolution Medicines (RVMD) in Q3 2026: 133 shares worth $27.3K. The stake represents 0.01% of the portfolio and ranks #215 among its holdings.

17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Burkett Financial Services held 133 shares of Revolution Medicines worth $27.3K as of Q3 2026.
Revolution Medicines was a new Burkett Financial Services position in Q3 2026.
Revolution Medicines made up 0.01% of Burkett Financial Services's portfolio in Q3 2026, its #215 holding.
17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.